Schupp, T.; Behnes, M.; Abumayyaleh, M.; Weidner, K.; Mashayekhi, K.; Bertsch, T.; Akin, I.
Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias. J. Clin. Med. 2022, 11, 1460.
https://doi.org/10.3390/jcm11051460
AMA Style
Schupp T, Behnes M, Abumayyaleh M, Weidner K, Mashayekhi K, Bertsch T, Akin I.
Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias. Journal of Clinical Medicine. 2022; 11(5):1460.
https://doi.org/10.3390/jcm11051460
Chicago/Turabian Style
Schupp, Tobias, Michael Behnes, Mohammad Abumayyaleh, Kathrin Weidner, Kambis Mashayekhi, Thomas Bertsch, and Ibrahim Akin.
2022. "Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias" Journal of Clinical Medicine 11, no. 5: 1460.
https://doi.org/10.3390/jcm11051460
APA Style
Schupp, T., Behnes, M., Abumayyaleh, M., Weidner, K., Mashayekhi, K., Bertsch, T., & Akin, I.
(2022). Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias. Journal of Clinical Medicine, 11(5), 1460.
https://doi.org/10.3390/jcm11051460